
==== Front
World J Pediatr Surg
World J Pediatr Surg
wjps
wjps
World Journal of Pediatric Surgery
2096-6938
2516-5410
BMJ Publishing Group BMA House, Tavistock Square, London, WC1H 9JR

39183805
10.1136/wjps-2024-000884
wjps-2024-000884
Review
1506
Role of genetics and the environment in the etiology of congenital diaphragmatichernia
Liu Siyuan 13190102278@zju.edu.cn

http://orcid.org/0000-0002-8693-5987
Yu Lan 2yulan20@zju.edu.cn

1 Department of Cardiac & Thoracic Surgery, Children’s Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, Hangzhou, Zhejiang, China
2 National Clinical Research Center for Child Health, Children's Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China
LanYu; yulan20@zju.edu.cn
None declared.

2024
21 8 2024
7 3 e00088424 6 2024
22 7 2024
Copyright © Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
2024
https://creativecommons.org/licenses/by-nc/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.

Abstract

Congenital diaphragmatic hernia (CDH) is a congenital malformation characterized by failure of diaphragm closure during embryonic development, leading to pulmonary hypoplasia and pulmonary hypertension, which contribute significantly to morbidity and mortality. The occurrence of CDH and pulmonary hypoplasia is theorized to result from both abnormalities in signaling pathways of smooth muscle cells in pleuroperitoneal folds and mechanical compression by abdominal organs within the chest cavity on the developing lungs. Although, the precise etiology of diaphragm maldevelopment in CDH is not fully understood, it is believed that interplay between genes and the environment contributes to its onset. Approximately 30% of patients with CDH possess chromosomal or single gene defects and these patients tend to have inferior outcomes compared with those without genetic associations. At present, approximately 150 gene variants have been linked to the occurrence of CDH. The variable expression of the CDH phenotype in the presence of a recognized genetic predisposition can be explained by an environmental effect on gene penetrance and expression. The retinoic acid pathway is thought to play an essential role in the interactions of genes and environment in CDH. However, apart from the gradually maturing retinol hypothesis, there is limited evidence implicating other environmental factors in CDH occurrence. This review aims to describe the pathogenesis of CDH by summarizing the genetic defects and potential environmental influences on CDH development.

Congenital Abnormalities
Zhejiang Provincial Natural Science Foundation of China LY24H020002
==== Body
pmcIntroduction

Birth defects are defined as structural or functional anomalies that impact physical, intellectual, or social well-being. The prevalence of birth defects is approximately 3%-6%, affecting 8 million newborns globally each year.1 According to the 2019 Global Burden of Diseases statistics,1 a total of 549 305 (7.1%) children died due to birth defects. Although progress is being made in understanding birth defect causation, up to 80% of cases still lack a known cause.2 Genetic factors contribute to approximately 25% of birth defects including monogenic defects such as achondroplasia3 and chromosomal defects such as Down syndrome.4 Environmental factors account for about 10%5 of birth defect causes including teratogenic exposures such as thalidomide,6 alcohol,7 and certain drugs during pregnancy. In addition, the majority of birth defects including congenital heart defects and congenital diaphragmatic hernia (CDH)8 are felt to result from interactions between genes and environment. In this review, we summarize the genetic and environmental factors thought to play contributing roles in the development of CDH.

Overview of congenital diaphragmatic hernia

CDH is a rare structural-developmental anomaly affecting approximately 2.3 per 10 000 live births.9 It is characterized by failure of closure of the diaphragm during embryonic development resulting in herniation of abdominal organs into the chest cavity. Despite improvements in prenatal diagnosis, surgical treatment, and postoperative monitoring and management of CDH, infant mortality is still in the range of 30%–50%.10 Pulmonary hypoplasia and pulmonary hypertension are the main causes of death in CDH patients, while long-term morbidity11 may be a significant concern in survivors.

Anatomic classification of CDH

CDH can be categorized into three anatomic types. The developing diaphragm contains a vulnerable region known as the lumbar rib triangle, situated on its posterior lateral side. Diaphragmatic hernias in this location are called Bochdalek or thoracoabdominal hiatus hernias. Bochdalek hernias account for approximately 70% of all CDH cases12 with 85% of Bochdalek hernias being left-sided.13 The second most common (27%) type of CDH occurs ventrally, and is known as a Morgagni or posterior sternal hernia.12 The third type is a centrally located hernia, also known as a septum transversum hernia, which occurs in 2%–3% of patients with CDH.12

Associated malformations

The clinical manifestations of CDH are closely tied to its type, the presence and severity of lung and pulmonary vascular maldevelopment, and the coexistence of associated malformations which occur in approximately 40% of patients.14 These concurrent malformations range from clinically insignificant to lethal. Cardiovascular and urogenital anomalies are the most commonly associated malformations,15 while othersincluding congenital eye,16 spinal,17 and limb reduction defects18 are infrequently observed. CDH can also be syndromic with recognized malformation patterns (e.g., Fryns, Simpson-Golabi-Behmel syndromes). Recognizing and describing these associations with CDH is useful for both hypothesizing disease pathogenesis, prognosticating outcomes and establishing appropriate trajectories of care for families, especially when the diagnoses are made prenatally.

The role of genes and the environment in CDH

It is likely that both genes and the environment contribute to CDH occurrence. At present, more than 40 genetic knockout mouse models associated with CDH have been successfully constructed, with most of these mice exhibiting a diaphragmatic defect accompanied by a pulmonary hypoplasia phenotype.19 This not only demonstrates the direct connection between genes and CDH occurrence, but also highlights the substantial genetic heterogeneity of CDH. In humans, nearly 30% of CDH cases can be attributed to a variety of genetic factors, including chromosomal anomalies (10%) such as aneuploidies, structural rearrangements, and copy number variations (CNVs),20 and individual gene anomalies (10%–22%) such as de novo damaging variants including single nucleotide variants and small insertions or deletions (indels).21 Included among the approximately 150 gene variants identified in association with CDH,22 more than 70 are single gene syndromes.14 Although there is no direct evidence of environmental causation in human CDH, several (but not all) population-based correlative studies suggest maternal exposure risk factors for CDH including maternal age,9 alcohol,23 pregestational diabetes,24 smoking,25 and agricultural pesticide exposure.2628

Embryology of human diaphragmatic development

The diaphragm is derived from mesenchyme and is composed of muscle, connective tissue (tendon), nerve, and blood vessels. From the embryologic perspective, the diaphragm muscle originates from the paraxial mesoderm, while the central tendon originates from the transverse septum of the splanchnic mesoderm.29 Normal development of the diaphragm involves four phases: Formation of the pleuroperitoneal folds (PPFs), formation of the postnatal mesenchymal plate, formation of the diaphragm, and closure of the pleuroperitoneal canal29 (figure 1). The development of the diaphragm occurs between the 4th and 12th weeks of development.22 By the 5th week, the PPFs that separate the thoracic and abdominal cavities begin to extend into the surrounding regions, eventually merging with the diaphragm and mesentery of the esophagus. By the 8th week of embryonic development, the PPFs, postnatal mesenchymal plate, and diaphragms have all fully matured, and the pleuroperitoneal canals have closed leading to the complete separation of the thoracic and abdominal cavities.8 30 Failure of closure of the pleuroperitoneal canal by week 10 when reduction of physiological midgut herniation occurs results in visceral herniation through the Bochdalek foramen into the chest, usually on the left side.

Figure 1 The normal embryological development of the diaphragm. (A) By the 5th week of human embryonic development, PPFs separating the chest and abdominal cavity begins to form and extends horizontally to the surrounding area. (B) By the 6th week, PPFs further expand and gradually fuse with the diaphragm and mesentery of the esophagus. The postnatal mesenchymal plate begins to form and develop. (C) By the 7th week, PPFs are basically mature, and the postnatal mesenchymal plate continues to develop. The diaphragm and other muscle connective tissue begin to form. (D) By the 8th week, the PPFs, postnatal mesenchymal plate, and diaphragm have fully matured, the pleuroperitoneal canals have closed, and the chest and abdominal cavity have also been completely separated by the diaphragm. CT, central tendon; E, esophagus; Lu, lung; NT, neural tube; PPFs, pleuroperitoneal folds; ST, septum transversum.

During embryonic development, muscle progenitor cells (myoblasts) originating from the somites migrate and integrate into the developing PPFs. Coincident with myoblast migration, the phrenic nerves exit the cervical spinal cord following the septum transversum and migrating myoblasts, leading to diaphragmatic innervation. The migration, proliferation, differentiation, and functional impact of these muscle progenitor cells are regulated by myogenic regulatory transcription factors, such as Myf5, MyoD, and myogenin.8 When the signaling pathways of muscle progenitor cells within the PPF are disrupted, muscular development is affected contributing to the occurrence of CDH.

Pulmonary hypoplasia in CDH

Pulmonary hypoplasia is a critical determinant of mortality in patients with CDH, yet its exact etiology is unknown. It is theorized that both the mechanical compression of the developing lungs by abdominal organs within the chest cavity and an abnormal signaling pathway of smooth muscle cells in PPFs, which dysregulates migration of progenitor smooth muscle airway cells, lead to the simultaneous occurrence of CDH and pulmonary hypoplasia.29 Accordingly, two explanatory hypotheses have been proposed.

Mechanical compression paradigm

While evidence exists that mechanical compression of the developing lung leads to a reduction of ipsilateral lung growth,31 the etiology of pulmonary hypoplasia, which is known to affect both lungs in human CDH, is likely more complex. In the nitrofen rat model (described in a future section), pulmonary hypoplasia is evident prior to the development of the mediastinum and diaphragm.32 In addition, other human pathologies that cause ipsilateral and contralateral (through mediastinal displacement) lung compression, such as large, space-occupying fetal lung lesions are not associated with the development of pulmonary hypoplasia observed in CDH.33 These observations suggest that pulmonary hypoplasia in CDH does not arise solely from mechanical compression, but is likely also influenced by factors that initiate pulmonary hypoplasia earlier in embryonic development prior to the onset of mechanical compression.

Dual-hit hypothesis

Given the limitations of the mechanical compression theory, attention has shifted towards understanding the developmental role of the embryonic mediastinum in human CDH, specifically the role of pulmonary mesothelial cells and their ability to undergo epithelial–mesenchymal transition and cellular differentiation.34 The “smooth muscle hypothesis” suggests that mesenchymally-derived progenitor cells of airway smooth muscle produce FGF-10. FGF-10 plays a crucial role in promoting the growth of pulmonary branches and facilitating the differentiation and coordination of airway smooth muscle contraction during the embryonic stage ensuring normal lung development.35 In the presence of abnormal epithelial–mesenchymal transition, there is dysfunction of airway smooth muscle cells responsible for producing FGF-10, which likely contributes to the development of pulmonary hypoplasia.36 In addition, mesenchymal cell maldevelopment can also lead to dysregulation of pulmonary vascular smooth muscle, further contributing to the characteristic features of pulmonary arterial hypertension.37 Moreover, studies have shown that in CDH models with pulmonary hypoplasia, treatment with amniotic fluid stem cell-derived extracellular vesicles (AFSC-EVs) can lead to phenotypes of alveolarization and branching in the previously underdeveloped lungs. AFSC-EV is a type of nanoparticle that combines AFSCs with a biofilm, which enhances the function and activity of mesenchymal cells indicating the important role of mesenchymal action in the embryonic development of the diaphragm and lungs.38

These data suggest plausibility for a dual-hit mechanism39 as being responsible for pulmonary hypoplasia in human CDH: The initial hit involves aberrant smooth muscle cell signaling within PPFs during early embryonic development. This disruption triggers abnormal epithelial–mesenchymal transition leading to primary pulmonary hypoplasia. The second hit is the mechanical compression of the developing lungs caused by abdominal organs entering the chest, further exacerbating the severity of pulmonary hypoplasia.

Animal models of CDH

Researchers have successfully established animal models of CDH by interfering with normal diaphragm development in the embryo using three methods: Surgical creation of a diaphragmatic hernia (sheep, rabbits), pharmacological interference (nitrofen rat model), and gene knockout techniques in mice. This discussion will focus on rodent models of CDH.

The most frequently used animal model for studying CDH involves the use of the herbicide nitrofen (2,4-dichlorophenyl-p-nitrophenyl ether).12 Administering nitrofen to pregnant rats on the 9th day of their 21-day gestation results in abnormal development of the heart, lungs, diaphragm, and embryonic skeleton in newborn pups.39 Characteristics of nitrofen-induced teratogenesis in the rat closely resemble the findings of human CDH making it a valuable tool for investigating the underlying mechanisms of CDH.40 Importantly, in the rat embryo, lung development begins on the 11th day of pregnancy. If the dams are exposed to nitrofen on the 9th day of pregnancy, approximately 70% of newborn pups develop CDH, and almost all of them exhibit pulmonary hypoplasia.40

With advancements in gene knockout technology, more than 40 gene knockout mouse models, including Gata48 41 and COUP-TFII,4244 have been developed for functional investigation of signaling pathways on the diaphragm and fetal lung development (table 1). The Gata4 heterozygous mouse model is one of the most commonly used animal models for studying birth defects. A notable proportion of Gata4 heterozygous mice die within 1 day of birth, exhibiting one or multiple developmental defects such as midline diaphragmatic hernias, dilated distal airways, and cardiac malformations.41 Furthermore, all Gata4 conditional knockout mice exhibit maldeveloped diaphragms with nearly 70% of pups possessing Bochdalek hernias.8 COUP-TFII is an important gene in mammalian embryonic development and is highly expressed in the mesenchymal components of different organs. Mice with homozygous deletion of COUP-TFII generally die within 10 days after birth due to growth restriction and severe bleeding caused by defects in angiogenesis and vascular remodeling.42 Compared with wild-type mice, COUP-TFII heterozygotes have smaller body sizes, various cardiovascular developmental abnormalities, and embryonic developmental issues, including those affecting the diaphragm.43 44

Table 1 Genetic mice models of CDH with lung abnormalities

Gene	Full gene name	Model	Diaphragmatic defects	Lung abnormalities	PMID	
CTNNB1	Catenin (cadherin associated protein), b1	Ctnnb1 fl2-6/fl2-6	Diaphragmatic hernia	Absent lung buds	26 278 035	
EYA1, EYA2	EYA transcriptional co-activator and phosphatase 1 and 2	Eya1 -/- , Eya2 -/+	Amuscular diaphragm	Pulmonary hypoplasia, abnormal epithelium morphologic features	24 528 972	
FGFRL1	Fibroblast Growth Factor Receptor Like 1	Fgfrl1 del1-2/del1-2 or Fgfrl1 del3-7/del3-7	Posterior diaphragm muscle	–	19383940,17986259	
FRAS1	Fraser extracellular matrix complex, subunit 1	Fras1 Q1263*/Q1263*	Retrosternal hernia (with sac)	–	29 618 029	
FREM1	Fras1-related extracellular matrix 1	Frem1 eyes2/eyes2	Retrosternal hernia (with sac)	Long lobulation defects, fused pulmonary lobes	23 221 805	
FREM2	Fras1-related extracellular matrix 2	Frem2 ne/ne	Retrosternal hernia (with sac)	Fused pulmonary lobes	29 618 029	
GAB1	GRB2 Associated Binding Protein 1	Gab1 LacZ/LacZ	Amuscular diaphragm	–	10 995 442	
GATA4	GATA-binging protein 4	Gata4 del2/+ ; Gata4 del3-5/fl3-5	Retrosternal hernia (with sac)	Dilated distal airways, increased saccule size, thickened mesenchyme, abnormal vasculature	25807280,17069789	
GLI2, GLI3	GLI familiy zinc finger 2 and 3	Gli2 -/- ;Gli3 -/- or Gli3 +/-	Posterior hernia	Hypoplasia, absent right accessory lobe, thickened mesenchyme	9 731 531	
HLX	H2.0-like homeobox	Hlx neo/neo	Muscular hypoplasia with unspecified hernia	Enlarged lungs with normal structure	8 557 196	
KIF7	Kinesin family number 7	Kif7 dd/dd or Kif7 maki	Posterior hernia	Hypoplasia, reduced alveolar epithelial cell differentiation	23 650 387	
LOX	Lysyl oxidasec	Lox neo/neo	Central hernia with rupture	Hypoplasia, abnormal acini, abnormal elastic fibers	12 473 682	
MET	Mesenchymal-epithelial transition factor	Met neo/neo	Diaphragmatic hernia, thin diaphragm muscle	Abnormal saccule morphologic features	12 388 344	
MYOD1	Myogenic differentiation 1	Myod1 neo/neo	Thin diaphragm muscle	Pulmonary hypoplasia	14 499 644	
NDST1	N-deacetylase-N-sulfotransferase 1	Ndst1 fl2/fl2	Central hernia	Thick interalveolar septa	24 355 925	
NR2F2	Nuclear receptor subfamily 2, group F, number 2	Nr2f2 fl1-3/fl1-3	Posterolateral hernia	Hypoplasia	16 251 273	
PAX3	Paired Box 3	Pax3 Sp/Sp	Amuscular diaphragm	–	10 226 008	
PBX1	Pre-B-cell leukemia transcription factor 1	Pbx1 neo/neo	Muscularization and tissue patterning defect	Hypoplasia, alveolar simplification	22 315 423	
PDGFRα	Platelet-derived growth factor receptor, α	Pdgfrα del2-4/del2-4	Posterolateral hernia	Hypoplasia, failure of alveogenesis	17 568 391	
PLS3	Plastin 3	Pls3 W499C ； Pls3 14bpdel	Posterolateral and anterior muscular thinning, hernia	–	37 751 738	
RARα, RARβ	Retinoic acid receptor α and β	Rarα neo/neo ,Rarβ neo/neo	Posterior hernia	Hypoplasia, abnormal alveoli, lung agenesis	7 607 068	
SIN3A	SIN3 transcription regulator family member A	Sin3a CKO	Left-sided diaphragm malformation	Pulmonary hypoplasia, pulmonary hypertension	38 295 182	
SIX1	Six homeobox 1	Six1 -/-	Absent diaphragm	Hypoplasia, reduced branching morphogenesis, narrow bronchi, arrested expansion of epithelial tubules, dense mesenchymal cellularity, failure of lung maturation	24 528 972	
SLIT3	Slit guidance ligand 3	Slit3 lacZ/lacZ	Central hernia (with sac)	–	12 702 769	
SOX7	Sex determining region Y-box 7	Sox7 del2/+	Retrosternal hernia (with sac)	–	22 723 016	
WT1	Wilms tumor 1	Wt1 del1/del1 ; Wt1 fl1/fl1	Posterolateral hernia	Hypoplasia, abnormally fused and malformed lung lobes, collapsed distal air spaces	27642710,17071579	

Genetic implications in human CDH

As noted previously, approximately 30% of patients with CDH have disease-causing genetic aberrations with chromosomal imbalance or single genetic de novo or inherited variants,45 46 and these patients typically experience inferior outcomes compared with patients with CDH without genetic aberrations.47 Syndromic CDH, which accounts for approximately 8% of all cases, is a recognizable constellation of anomalies that include CDH.48 It includes monogenic syndromes (3.2%), syndromes with chromosomal anomalies or microdeletions/duplications (3.1%), and other syndromes with unknown genetic causes (1.9%). When compared with non-syndromic CDH, patients with syndromic CDH demonstrate lower birth weight, increased rates of prematurity, higher rate of bilateral CDH, lower survival rates, and higher rates of non-repair.48

Monogenic syndromes with CDH

The monogenic syndromes associated with CDH can be classified according to their inheritance patterns: Autosomal recessive, autosomal dominant, and X-linked (table 2). The following are representative syndromes that co-occur with CDH.

Table 2 Monogenic syndromes related to CDH

Inheritance model	Syndrome	Gene	Chromosome	Phenotype	% with CDH	PMID	
Autosomal recessive	Donnai–Barrow syndrome	LRP2	2q31.1	Agenesis of the corpus callosum, facial dysmorphology, ocular anomalies, sensorineural hearing loss and developmental delay	43%	25 682 901	
Autosomal recessive	Fryns syndrome	PIGN	18q21.3	CDH, craniofacial anomalies, distal limb hypoplasia, Cardiac anomalies and internal malformations	10%	37418285,12483630	
Autosomal recessive	Cutis laxa	LTBP4	19q13.2	Loose and/or wrinkled skin, pulmonary emphysema and/or vascular complications.	56%	19836010,22829427	
Autosomal recessive	Pulmonary hypoplasia, Diaphragmatic anomalies, microphthalmia, and Cardiac defects (PDAC) syndrome	STRA6 or RARB	15q24.1 or 3 p24	Small or absent eyes, heart defects, CDH, pulmonary hypoplasia and renal malformations	Rare	22686418,24075189	
Autosomal dominant	Denys–Drash syndrome	WT1	11 p13	Male pseudohermaphroditism, GU anomalies, renal anomalies, nephrotic syndrome. Wilms tumor predisposition	Rare	7 645 607	
Autosomal dominant	Meacham syndrome	WT1	11 p13	Male pseudohermaphroditism, GU anomalies, renal anomalies, nephrotic syndrome, CHD, Wilms tumor predisposition	Rare	16 932 893	
Autosomal dominant	Frasier syndrome	WT1	11 p13	Male pseudohermaphroditism, GU anomalies, renal anomalies, nephrotic syndrome	Rare	10 792 605	
Autosomal dominant	MYRF-related cardiac urogenital syndrome	MYRF	11q12.2	Urogenital defects, congenital heart defects and eye anomalies	62.5%	31 069 960	
Autosomal dominant	Cornelia (Brachmann) de Lange syndrome	NIPBL	5 p13.2	Limb defects, dysmorphic features: synophrys, brachyrrhinia, long philtrum, thin lip,	5~20%	32 762 940	
X-linked	Simpson–Golabi–Behmel syndrome	GPC3	Xq26.2	Prenatal/ postnatal overgrowth, coarse facies, bifid uvula, macroglossia, macrognathia, CHD, rib anomalies, renal anomalies, nephromegaly, Wilms tumor predisposition	24%	20 950 395	
X-linked	Craniofrontonasal syndrome	EFNB1	Xq13.1	Coronal synostosis, hypertelorism, facial asymmetry, bifid nasal tip and skeletal anomalies	Rare	16639408,32022998	

Autosomal recessive

Fryns syndrome (OMIM: 229 850) is an autosomal recessive multiple anomaly syndrome that includes CDH, craniofacial anomalies, distal limb hypoplasia, cardiac anomalies, and internal malformations. It is the most common syndrome associated with CDH (>90%), accounting for 1.3%–10% of all cases.48 49 Biallelic PIGN mutations have been described in Fryns syndrome.50 However, not all patients meeting the diagnostic criteria for Fryns syndrome carry PIGN mutations, suggesting genetic heterogeneity.

Donnai-Barrow syndrome (DBS; OMIM: 222448) is a rare autosomal recessive genetic disorder characterized by craniofacial anomalies, high myopia, sensorineural hearing loss, and low molecular weight proteinuria. Mutations in the LDL receptor-related protein 2 (LRP2) gene can result in DBS.51 Approximately 43% of cases of DBS have an associated CDH phenotype.52

Pulmonary hypoplasia, diaphragmatic anomalies, microphthalmia, and cardiac defects (PDAC) syndrome is a rare monogenic disease with a complex clinical phenotype including small or absent eyes, heart defects (55%), congenital diaphragmatic hernia (29%), pulmonary hypoplasia (39%), and renal malformations.53 It is caused by the recessive mutations in the retinol-binding protein gene STRA6 or recessive and dominant mutations in the retinoic acid receptor beta (RARB) gene.54

Cutis laxa is a group of rare connective tissue disorders characterized by loose and/or wrinkled skin. Mutations in the gene coding the latent transforming growth factor beta binding protein 4 (LTBP4) will cause cutis laxa and other physical system problems including pulmonary, gastrointestinal, genitourinary, and musculoskeletal malformations. Approximately 56% of patients with LTBP4 recessive mutations will have CDH.55 56

Autosomal dominant

Denys-Drash syndrome (DDS; OMIM 194080), Meacham syndrome (MS; OMIM 608978), and Frasier syndrome (FS; OMIM 136680) are all genetic diseases caused by dominant mutations in the Wilms tumor suppressor gene WT1 that are rarely associated with CDH.5759 DDS and FS are both early renal developmental disorders, and their clinical features include male pseudohermaphroditism and progressive glomerular disease.57 60 DDS can also lead to the development of Wilms tumor, and patients may experience end-stage renal failure earlier.61 MS is an autosomal dominant congenital connective tissue disease characterized by developmental abnormalities in the skeletal and cardiovascular systems.58 Early onset Marfan syndrome (EOMS) is the most severe type of MS and approximately 20% of EOMS patients exhibit a phenotype of diaphragmatic eventration.62 How the loss of WT1 function alone might directly induce diaphragmatic defects, or whether other genetic or environmental conditions are also necessary for this to occur is unknown.

MYRF-related cardiac urogenital syndrome (MYRF-CUGS) is primarily characterized by urogenital defects, congenital heart defects, and eye anomalies. Other features of the condition include a broad range of developmental delay/intellectual disability, pulmonary hypoplasia and CDH. It is the result of de novo dominant mutations in a myelin regulatory factor (MYRF) gene.63 MYRF is a membrane-related transcription factor. It is highly expressed during the embryonic development of the heart and diaphragm.64 65 Approximately 60% of MYRF-CUGS will present with CDH.66

Cornelia de Lange syndrome 1 (CDLS1; OMIM 122470) is a rare genetic syndrome caused by mutations of NIPBL cohesin loading factor (NIPBL). It is characterized by proportional short stature and characteristic facial features accompanied by heart defects, and genital abnormalities. CDH occurs in 5%–20% of patients with CDLS and has a reported mortality of approximately 80%.67

X-linked syndromes

Simpson Golabi Behmel syndrome (OMIM 312870) is an X-linked recessive disorder caused by mutations in the GPC3 gene, which is highly expressed in embryonic mesoderm and is involved in local growth regulation. It is characterized by excessive fetal and neonatal growth, dysmorphic features and multiple congenital anomalies, including CDH in approximately 24% of cases.68

Craniofrontonasal syndrome (CFNS; OMIM 304110) is an X-linked dominant condition caused by mutations in Ephrin B1 (EFNB1) gene69 that is characterized by coronal synostosis, hypertelorism, facial asymmetry, bifid nasal tip, and skeletal anomalies. Women with CFNS are more severely affected than men.70 CDH is reported in both affected men and women with CFNS.71

Chromosomal anomalies in CDH

Chromosomal anomalies, especially de novo events spanning multiple genes including complete or partial aneuploidy, cytogenetic rearrangements, and CNVs are present in approximately 10% of patients with CDH.20 Aneuploidies associated with CDH mainly include trisomy 18 (Edwards syndrome), trisomy 21, trisomy 13, Turner syndrome (45, X), Trisomy X (46, XXX), and Pallister-Killian syndrome (PKS).14 PKS is a rare chromosomal disease caused by short-arm tetrasomic chimerism on chromosome 12 and the occurrence of CDH in combination with PKS is in the range of 5%–27%.72

The CNVs associated with the occurrence of CDH include 8p23.1 deletion, 15q26.1 deletion, 1q41-42 deletion, 8q23.1 deletion, 4p16 deletion, 3q22 deletion, 4p16 deletion, 6p25 deletion, 11p13 deletion, 11q23.2 duplications, 1q25q31.2 duplications, 8p21-p23.1 duplications, and unbalanced translocation of der22 t(11:22)(q23:q11).14 20 The majority of CNVs are deleted copy numbers of candidate genes associated with CDH occurrence. Notably, deletion of 8p23.1 is the most common CNV associated with CDH accounting for 3%–5% of patients with CDH.20 73 The deleted 8p23.1 region precisely contains the GATA binding protein 4 (GATA4) and SRY-box transcription factor 7 (SOX7) genes, which are important transcription factors in the development of the heart and diaphragm and have been confirmed to be closely related to the occurrence of CDH.73 Similarly, the deleted region of 15q26.1 contains the protein-encoding gene nuclear receptor subfamily 2 group F member 2 (NR2F2, also known as COUP-TFII),43 accounting for approximately 1.5% of patients with CDH14; 1q41-42 deletion contains the H2.0 like homeobox (HLX) and dispatched RND transporter family member 1 (DISP1) genes; CNVs in these regions have been associated with Fryns syndrome with CDH, dysmorphic features, and other multiple congenital anomalies.

The 4p16 deletion contains fibroblast growth factor receiver like 1 (FGFRL1); 11p13 deletion contains Wilms tumor 1 (WT1) gene; 8q23 deletion includes zinc finger protein family member 2 (ZFPM2); 3q12 deletion contains the candidate genes for cellular retinol-binding proton 1 (RBP1) and cellular retinol-binding proton 2 (RBP2).14 74

Genes identified in non-syndromic CDH

The use of next-generation sequencing techniques has proven invaluable in identifying candidate genes in patients with CDH. There are more than 150 gene variants identified in patients with CDH.22 Notably, genes such as GATA4, the GATA binding protein 6 (GATA6), zinc finger protein, FOG family member 2 (FOG2), and Lon peptidase 1 (LONP1) (table 3) are suspected to be involved in diaphragm development.75

Table 3 Overview of candidate genes for human CDH

Gene	GATA4	GATA6	ZFPM2	NR2F2	LONP1	
Gene Locus	8q23.1	18q11.2	8q23.1	15q26.2	19q13.3	
Expression	Lung mesenchyme, diaphragm, liver	Lung mesenchyme, diaphragm	Lung mesenchyme, diaphragm	Lung mesenchyme	Lung, heart, skeletal muscle	
Function	Transcription factor	Transcription factor	Transcription factor	Transcription factor	Mitochondrial protease	
Protein Activity	Zinc finger transcription	Zinc finger transcription	Zinc finger protein Regulating the expression of GATA	Nuclear receptor subfamily two group F	Bind to mtDNA and degrade damaged proteins	
Anomalies Associated	Congenital Heart Disease, Atrial Septal Defect,Testicular Anomalies	Diaphragmatic Hernia, Congenital Heart Defects, Pancreatic Agenesis	Diaphragmatic Hernia, 46Xy Sex Reversal, Tetralogy Of Fallot	Congenital Heart Defects, Xx Sex Reversal	Codas (Cerebral, Ocular, Dental, Auricular And Skeletal) Syndrome	

GATA genes

GATA4 is located at 8q23.1. GATA transcription factors are a family of transcription factors with zinc finger domains, composed of six subtypes. GATA1, GATA2, and GATA3 are hematopoietic expression factors, while GATA4, GATA5, and GATA6 (and especially GATA4) play important roles in heart and endoderm development.76 The GATA4 gene is highly expressed in cells of PPFs during the embryonic stage. De novo GATA4 mutations have been identified in patients with CDH.46 77 Gata4−/− mice experience embryonic lethality; but heterozygotes develop midline diaphragm defects in approximately 15% of offspring.41 Moreover, conditional deletion of Gata4 in the PPF caused diaphragm defects in all mutant mice.8

Approximately 18% of GATA6 mutants cause diaphragmatic hernia.78 GATA6 is only expressed in the mesenchymal region of PPFs, but plays a pivotal role in the regulation of mammalian hematopoietic and cardiac development.76 In the nitrofen rat model, the expression of Gata6 was significantly reduced in the PPFs and lung interstitium.79 In GATA6 gene knockouts, mRNA expression of Clara cell 10 kDa proteins (CC10) and surfactant protein C (SPC) markers for proximal and distal lung epithelial cells differentiation is significantly reduced,80 suggesting the impact of GATA6 gene on pulmonary growth and maturation in CDH. Furthermore, deletion of the GATA6 gene leads to the activation of the Wnt/-catenin signaling in the lungs, influencing the growth and differentiation of developing lung epithelial cells, ultimately resulting in decreased lung tissue branching.81

FOG2

FOG2 (also known as ZFPM2), located at 8q23.1, encodes a transcription factor that regulates the expression activities of GATA4 and GATA6.82 Studies have shown that mice with FOG2 gene deletion exhibit significantly reduced hepatocyte growth factor/scattering factor (HGF) expression and a higher incidence of CDH.82 The deletion of FOG2 is believed to impact the HGF/c-MET signaling pathway and the migration of muscle progenitor cells to PPFs leading to diaphragm and lung maldevelopment.22 Genetic analysis of a multigenerational family identified a heritable intragenic FOG2 deletion with an estimated penetrance of 37.5%.83

Other implicated genes

The COUP-TFII gene, also known as the NR2F2 gene, is located at 15q26.2 of the common CNVs associated with CDH.84 Conditional deletion of COUP-TFII in the PPF induces Bochdalek CDH in ∼50% of offspring.44 At least 10 loss of function variants in NR2F2 have been identified in patients with CDH.43 LONP1 is a nuclear-encoded mitochondrial protease with ATP-dependent protease activity, crucial for degrading misfolded or damaged proteins. Analysis of de novo and inherited rare genetic variants highlight LONP1 as a potential risk gene for CDH. Notably, patients with LONP1 variants not only had CDH, but also had cardiac structural abnormalities or skeletal abnormalities. In addition, the loss of LONP1 in embryonic lung epithelium of mice led to abnormal lung development and a 100% mortality rate at birth.85

Maternal and environmental risk factors in human CDH

No teratogens have been causally linked to human CDH. Maternal risk factors implicated from population-based case-control studies include maternal age (risk ratio (RR) =1.69, 95% confidence interval (CI) 1.26 to 2.25),9 pregestational diabetes (OR=12.53, 95% CI 2.40 to 65.43),24 smoking (OR=1.30, 95% CI 1.10 to 1.50),25 alcohol (OR=1.64, 95% CI 1.10 to 2.44),86 OR=2.9, 95% CI 1.6 to 5.2),23 and maternal periconceptional use of hairspray (OR=2.07, 95% CI 1.33 to 3.23).86

Several case-control studies have looked at preconceptual or periconceptual maternal dietary intake in relation to CDH occurrence in offspring. In one large study of nearly 5500 cases and controls from the National Birth Defects Prevention Study (NBDPS), ORs of 1.4 or higher were observed with lower (≤10th percentile) intake of lutein, selenium, and vitamin A. Conversely, ORs were decreased (0.7 or less) for≥90th percentile intakes of folate, iron, thiamin (B1), vitamin B6, and zinc.87 Other case-control studies have looked specifically at vitamin A intake and CDH occurrence. A Dutch study showed that daily vitamin A intake below recommended levels in normal-weight mothers was significantly associated with lower serum retinol levels and an increased CDH risk (OR=7.20, 95% CI 1.50 to 34.40).88 Conversely, a reduced risk of CDH was observed in similar normal-weight Japanese mothers with high maternal vitamin A intake (OR=0.50, 95% CI 0.20 to 1.00).89 Furthermore, clinical and experimental evidence suggest that maternal alcohol use and cigarette smoking modifies vitamin A metabolism,90 91 suggesting a possible mechanistic role for vitamin A in smoking or alcohol-related CDH occurrence.

It is important to acknowledge that the body of evidence describing environmental associations of CDH is inconsistent with some studies reporting no associations between CDH and smoking,27 alcohol consumption,25 or vitamin A intake.92 This suggests that the role of environmental exposure in the development of CDH is likely that of a modifier of genetic phenotype rather than as a direct teratogen.

Environmental and genetic interactions in CDH: role of the retinoic acid pathway

An attractive hypothesis to explain the variable expression of a CDH phenotype in the presence of known genetic predisposition is sensitization by environmental conditions (maternal and indirectly, environmental) on gene penetrance and expression. The retinoic acid (RA) pathway may play such a role in CDH.93 94 RA is a metabolite of dietary vitamin A. Vitamin A, sourced as β-carotene from plants and as retinol from animal-derived retinoids,95 is oxidized and metabolized in the liver to produce retinol. Retinol binds to RBP and transthyroxine and the RBP-retinol complex is actively internalized into cells through STRA6 to initiate intracellular signaling. Inside the cell, retinol binds to cytoplasmic retinol-binding protein-1 where it is oxidized to retinal by retinol dehydrogenase and then irreversibly dehydrogenated to the active molecule RA by cytosolic retinal dehydrogenases (RALDH). RA enters the cell nucleus and binds to intracellular RA receptors or retinol-like X receptors to form transcription factors. These factors bind to the retinoic acid responsive elements on the target gene, initiating the transcription of the target gene, thereby regulating gene transcription and expression22 (figure 2).

Figure 2 Environmental and genetic interactions in CDH. Dietary vitamin A undergoes oxidative metabolism in the liver, producing retinol. Retinol then binds to retinol binding protein (RBP) for transport in the blood. Retinol-RBP complex enters into specific cells, such as hepatic stellate cells or placental trophoblast cells, through transmembrane receptor STRA6. Inside the cell, retinol binds to retinol binding protein-1 (CRBP-1) and forms retinal under the action of retinol dehydrogenase (ROLDH), which further metabolizes retinoic acid (RA) under the action of retinal dehydrogenase (RALDH). RA enters the nucleus and binds to intracellular RA receptors (RARs) or retinol like X receptors (RXRs), while promoting the expression of GATA4, FOG2, WT1, and COUP-TFII genes. WT1 can activate the RALDH gene, thereby promoting RA signaling. COUP-TFII chelates RAR, inhibits RAR/RXR heterodimerization. GATA4 directly regulates the expression of the RARE gene promoter. FOG2 can bind to GATA4 and inhibit its expression. The interaction between the retinol signaling pathway and genes jointly regulates the transcription and expression of the RARE gene, maintaining the normal development of the diaphragm.

As noted previously, maternal vitamin A deficiency is associated with human CDH,95 and a number of mechanistic explanations are plausible. Low dietary vitamin A intake increases the incidence of teratogen-induced CDH in mice96 through inhibited RA synthesis via RALDH2.97 In addition, evidence from mice and humans suggest that genes involved in the RA signaling pathway can cause diaphragm defects. Mutations of the retinol-binding protein gene STRA6 and RA receptor beta (RARB) gene can cause PDAC syndrome which has a CDH/eventration phenotype in 29% of patients.53 RALDH2 is expressed in the developing diaphragm64 and mutations have been discovered in patients with a variety of different CDH phenotypes.98 99 Other genes such as RBP1 and RBP2, located in the recurrent 3q12 deletion region associated with CDH, could also be linked to CDH, although no specific gene mutations have been identified.100

RA target genes or genes that are involved in the interaction with RA receptor (RAR) are also implicated in CDH. As discussed above, genes of WT1, LRAT, COUP-TFII, FOG2, and GATA4 that interact with RAR in CDH have been observed in both animal models and human gene mutations associated with CDH. WT1 regulates the RA signaling by activating the RALDH2 gene.101 Interestingly, the diaphragmatic defect can be partially rescued by RA dietary supplement in conditional Wt1 deletion CDH mice.102 LRAT can esterify retinol to retinol esters, preventing the oxidation of retinol in cells and preventing its further role in the RA signaling pathway.93 COUP-TFII heterodimerizes with the RXR family to regulate gene expression.103 FOG2 interacts with GATA4104 and both are target genes of RA.105 It has been suggested that retinoids can regulate downstream gene expression through direct interaction with GATA4 and FOG2.106 In addition, TBX1 can interact with the transcription factor GATA4 through the GATA-TBX1 regulatory axis, promoting the expression of GATA4.99 Prenatal treatment with RA in the nitrofen model of CDH results in upregulated expression of COUP-TFII, FOG2, and GATA4.105

Conclusion

Although its precise origin remains uncertain, there is abundant evidence from mouse and human studies that genetics plays a key role in CDH development with more than 150 genetic variants implicated. Environmental/maternal factors such as vitamin A/retinoic acid likely interact with genes to contribute the phenotype of CDH. Enhanced understanding of how aberrant RA signaling can lead to abnormal diaphragm development should clarify insights into CDH pathogenesis. Because CDH is usually detected antenatally; there is an increasing need for rapid, accurate, and predictive genetic diagnostics to support prenatal decision-making. From the perspective of the parents of a child with CDH, it is important to provide accurate genetic forecasting of the severity of CDH-specific disease as well as the impact of associated anomalies on both survival and quality of life as well as the risk to subsequent children. Families must be offered comprehensive genetic counseling to make decisions based on a thorough understanding of the potential benefits and risks.

Funding: This study was funded by Zhejiang Provincial Natural Science Foundation of China (LY24H020002).

Patient consent for publication: Not applicable.

Ethics approval: Not applicable.

Provenance and peer review: Commissioned; externally peer reviewed.

Contributors: SL Contributed to data curation, visualization, writing original draft; LY contributed to conceptualization, funding acquisition, supervision, writing review and editing.
==== Refs
References

1 Zhao Y Zhang H Peng M et al The burden of congenital birth defects between 1990 and 2019 in China: an observational study Front Pediatr 2023 11 1170755 10.3389/fped.2023.1170755 37252046
2 Lipinski RJ Krauss RS Gene-environment interactions in birth defect etiology: challenges and opportunities Curr Top Dev Biol 2023 152 1 30 10.1016/bs.ctdb.2022.10.001 36707208
3 Charoenngam N Nasr A Shirvani A et al Hereditary Metabolic Bone Diseases: A Review of Pathogenesis, Diagnosis and Management Genes (Basel) 2022 13 1880 10.3390/genes13101880 36292765
4 Dimopoulos K Constantine A Clift P et al Cardiovascular Complications of Down Syndrome: Scoping Review and Expert Consensus Circulation 2023 147 425 41 10.1161/CIRCULATIONAHA.122.059706 36716257
5 Baldacci S Gorini F Santoro M et al Environmental and individual exposure and the risk of congenital anomalies: a review of recent epidemiological evidence Epidemiol Prev 2018 42 1 34 10.19191/EP18.3-4.S1.P001.057
6 Vargesson N Thalidomide-induced teratogenesis: history and mechanisms Birth Defects Res C Embryo Today 2015 105 140 56 10.1002/bdrc.21096 26043938
7 Caputo C Wood E Jabbour L Impact of fetal alcohol exposure on body systems: a systematic review Birth Defects Res C Embryo Today 2016 108 174 80 10.1002/bdrc.21129 27297122
8 Merrell AJ Ellis BJ Fox ZD et al Muscle connective tissue controls development of the diaphragm and is a source of congenital diaphragmatic hernias Nat Genet 2015 47 496 504 10.1038/ng.3250 25807280
9 Paoletti M Raffler G Gaffi MS et al Prevalence and risk factors for congenital diaphragmatic hernia: a global view J Pediatr Surg 2020 55 2297 307 10.1016/j.jpedsurg.2020.06.022 32690291
10 Gupta VS Harting MT Lally PA et al Mortality in Congenital Diaphragmatic Hernia: A Multicenter Registry Study of Over 5000 Patients Over 25 Years Ann Surg 2023 277 520 7 10.1097/SLA.0000000000005113 34334632
11 Cimbak N Buchmiller TL Long-term follow-up of patients with congenital diaphragmatic hernia World J Pediatr Surg 2024 7 e000758 10.1136/wjps-2023-000758 38618013
12 van Loenhout RB Tibboel D Post M et al Congenital diaphragmatic hernia: comparison of animal models and relevance to the human situation Neonatology 2009 96 137 49 10.1159/000209850 19325248
13 DeKoninck P Gomez O Sandaite I et al Right-sided congenital diaphragmatic hernia in a decade of fetal surgery BJOG 2015 122 940 6 10.1111/1471-0528.13065 25227954
14 Yu L Hernan RR Wynn J et al The influence of genetics in congenital diaphragmatic hernia Semin Perinatol 2020 44 151169 10.1053/j.semperi.2019.07.008 31443905
15 Teunissen NM Daniels H Schnater JM et al Prevalence and early surgical outcome of congenital diaphragmatic hernia in the Netherlands: a population-based cohort study from the European Pediatric Surgical Audit Arch Dis Child Fetal Neonatal Ed 2024 109 412 20 10.1136/archdischild-2023-326311 38195217
16 Steiner RD St J Dignan P Hopkin RJ et al Combination of diaphragmatic eventration and microphthalmia/anophthalmia is probably nonrandom Am J Med Genet 2002 108 45 50 10.1002/ajmg.10167 11857549
17 Grethel EJ Farrell J Ball R et al Congenital diaphragmatic hernia associated with spinal anomalies Obstet Gynecol 2007 109 485 8 10.1097/01.AOG.0000254174.25795.d6 17267867
18 van Dooren MF Brooks AS Tibboel D et al Association of congenital diaphragmatic hernia with limb‐reduction defects Birth Defects Res 2003 67 578 84 10.1002/bdra.10079
19 Friedmacher F Rolle U Puri P Genetically Modified Mouse Models of Congenital Diaphragmatic Hernia: Opportunities and Limitations for Studying Altered Lung Development Front Pediatr 2022 10 867307 10.3389/fped.2022.867307 35633948
20 Yu L Wynn J Ma L et al De novo copy number variants are associated with congenital diaphragmatic hernia J Med Genet 2012 49 650 9 10.1136/jmedgenet-2012-101135 23054247
21 Longoni M High FA Qi H et al Genome-wide enrichment of damaging de novo variants in patients with isolated and complex congenital diaphragmatic hernia Hum Genet 2017 136 679 91 10.1007/s00439-017-1774-y 28303347
22 Burns NG Kardon G The role of genes and environment in the etiology of congenital diaphragmatic hernias Curr Top Dev Biol 2023 152 115 38 10.1016/bs.ctdb.2022.10.004 36707209
23 Felix JF van Dooren MF Klaassens M et al Environmental factors in the etiology of esophageal atresia and congenital diaphragmatic hernia: results of a case‐control study Birth Defects Res 2008 82 98 105 10.1002/bdra.20423
24 McAteer JP Hecht A De Roos AJ et al Maternal medical and behavioral risk factors for congenital diaphragmatic hernia J Pediatr Surg 2014 49 34 8 10.1016/j.jpedsurg.2013.09.025 24439577
25 Finn J Suhl J Kancherla V et al Maternal cigarette smoking and alcohol consumption and congenital diaphragmatic hernia Birth Defects Res 2022 114 746 58 10.1002/bdr2.2059 35757961
26 Carmichael SL Yang W Roberts E et al Residential agricultural pesticide exposures and risks of selected birth defects among offspring in the San Joaquin Valley of California Birth Defects Res 2016 106 27 35 10.1002/bdra.23459
27 Caspers KM Oltean C Romitti PA et al Maternal periconceptional exposure to cigarette smoking and alcohol consumption and congenital diaphragmatic hernia Birth Defects Res A Clin Mol Teratol 2010 88 1040 9 10.1002/bdra.20716 20842650
28 Kielb C Lin S Herdt-Losavio M et al Maternal periconceptional occupational exposure to pesticides and selected musculoskeletal birth defects Int J Hyg Environ Health 2014 217 248 54 10.1016/j.ijheh.2013.06.003 23871272
29 Mayer S Metzger R Kluth D The embryology of the diaphragm Semin Pediatr Surg 2011 20 161 9 10.1053/j.sempedsurg.2011.03.006 21708336
30 Sefton EM Gallardo M Kardon G Developmental origin and morphogenesis of the diaphragm, an essential mammalian muscle Dev Biol 2018 440 64 73 10.1016/j.ydbio.2018.04.010 29679560
31 Nobuhara KK Wilson JM The effect of mechanical forces on in utero lung growth in congenital diaphragmatic hernia Clin Perinatol 1996 23 741 52 10.1016/S0095-5108(18)30206-9 8982568
32 Bargy F Beaudoin S Barbet P Fetal lung growth in congenital diaphragmatic hernia Fetal Diagn Ther 2006 21 39 44 10.1159/000089046 16354973
33 Derderian SC Jayme CM Cheng LS et al Mass Effect Alone May Not Explain Pulmonary Vascular Pathology in Severe Congenital Diaphragmatic Hernia Fetal Diagn Ther 2016 39 117 24 10.1159/000434643 26667230
34 van Loenhout RB Tseu I Fox EK et al The pulmonary mesenchymal tissue layer is defective in an in vitro recombinant model of nitrofen-induced lung hypoplasia Am J Pathol 2012 180 48 60 10.1016/j.ajpath.2011.09.032 22063298
35 Jesudason EC Small lungs and suspect smooth muscle: congenital diaphragmatic hernia and the smooth muscle hypothesis J Pediatr Surg 2006 41 431 5 10.1016/j.jpedsurg.2005.11.021 16481264
36 Min H Danilenko DM Scully SA et al Fgf-10 is required for both limb and lung development and exhibits striking functional similarity to Drosophila branchless Genes Dev 1998 12 3156 61 10.1101/gad.12.20.3156 9784490
37 Jesudason EC Smith NP Connell MG et al Developing rat lung has a sided pacemaker region for morphogenesis-related airway peristalsis Am J Respir Cell Mol Biol 2005 32 118 27 10.1165/rcmb.2004-0304OC 15576668
38 Antounians L Catania VD Montalva L et al Fetal lung underdevelopment is rescued by administration of amniotic fluid stem cell extracellular vesicles in rodents Sci Transl Med 2021 13 eaax5941 10.1126/scitranslmed.aax5941 33883273
39 Keijzer R Liu J Deimling J et al Dual-hit hypothesis explains pulmonary hypoplasia in the nitrofen model of congenital diaphragmatic hernia Am J Pathol 2000 156 1299 306 10.1016/S0002-9440(10)65000-6 10751355
40 Costlow RD Manson JM The heart and diaphragm: target organs in the neonatal death induced by nitrofen (2,4-dichlorophenyl-p-nitrophenyl ether) Toxicology 1981 20 209 27 10.1016/0300-483x(81)90052-4 7256786
41 Jay PY Bielinska M Erlich JM et al Impaired mesenchymal cell function in Gata4 mutant mice leads to diaphragmatic hernias and primary lung defects Dev Biol 2007 301 602 14 10.1016/j.ydbio.2006.09.050 17069789
42 Pereira FA Qiu Y Zhou G et al The orphan nuclear receptor COUP-TFII is required for angiogenesis and heart development Genes Dev 1999 13 1037 49 10.1101/gad.13.8.1037 10215630
43 Ganapathi M Matsuoka LS March M et al Heterozygous rare variants in NR2F2 cause a recognizable multiple congenital anomaly syndrome with developmental delays Eur J Hum Genet 2023 31 1117 24 10.1038/s41431-023-01434-5 37500725
44 You L-R Takamoto N Yu C-T et al Mouse lacking COUP-TFII as an animal model of Bochdalek-type congenital diaphragmatic hernia Proc Natl Acad Sci U S A 2005 102 16351 6 10.1073/pnas.0507832102 16251273
45 Bendixen C Reutter H The Role of De Novo Variants in Patients with Congenital Diaphragmatic Hernia Genes (Basel) 2021 12 1405 10.3390/genes12091405 34573387
46 Yu L Wynn J Cheung YH et al Variants in GATA4 are a rare cause of familial and sporadic congenital diaphragmatic hernia Hum Genet 2013 132 285 92 10.1007/s00439-012-1249-0 23138528
47 Qiao L Wynn J Yu L et al Likely damaging de novo variants in congenital diaphragmatic hernia patients are associated with worse clinical outcomes Genet Med 2020 22 2020 8 10.1038/s41436-020-0908-0 32719394
48 Burgos CM Gupta VS Conner P et al Syndromic congenital diaphragmatic hernia: current incidence and outcome. Analysis from the congenital diaphragmatic hernia study group registry Prenat Diagn 2023 43 1265 73 10.1002/pd.6407 37418285
49 Neville HL Jaksic T Wilson JM et al Fryns syndrome in children with congenital diaphragmatic hernia J Pediatr Surg 2002 37 1685 7 10.1053/jpsu.2002.36695 12483630
50 Loong L Tardivo A Knaus A et al Biallelic variants in PIGN cause Fryns syndrome, multiple congenital anomalies-hypotonia-seizures syndrome, and neurologic phenotypes: agenotype-phenotype correlation study Genet Med 2023 25 37 48 10.1016/j.gim.2022.09.007 36322149
51 Kantarci S Al-Gazali L Hill RS et al Mutations in LRP2, which encodes the multiligand receptor megalin, cause Donnai-Barrow and facio-oculo-acoustico-renal syndromes Nat Genet 2007 39 957 9 10.1038/ng2063 17632512
52 Khalifa O Al-Sahlawi Z Imtiaz F et al Variable expression pattern in Donnai-Barrow syndrome: report of two novel LRP2 mutations and review of the literature Eur J Med Genet 2015 58 293 9 10.1016/j.ejmg.2014.12.008 25682901
53 Chassaing N Ragge N Kariminejad A et al Mutation analysis of the STRA6 gene in isolated and non-isolated anophthalmia/microphthalmia Clin Genet 2013 83 244 50 10.1111/j.1399-0004.2012.01904.x 22686418
54 Srour M Chitayat D Caron V et al Recessive and dominant mutations in retinoic acid receptor beta in cases with microphthalmia and diaphragmatic hernia Am J Hum Genet 2013 93 765 72 10.1016/j.ajhg.2013.08.014 24075189
55 Urban Z Hucthagowder V Schürmann N et al Mutations in LTBP4 cause a syndrome of impaired pulmonary, gastrointestinal, genitourinary, musculoskeletal, and dermal development Am J Hum Genet 2009 85 593 605 10.1016/j.ajhg.2009.09.013 19836010
56 Callewaert B Su C-T Van Damme T et al Comprehensive clinical and molecular analysis of 12 families with type 1 recessive cutis laxa Hum Mutat 2013 34 111 21 10.1002/humu.22165 22829427
57 Devriendt K Deloof E Moerman P et al Diaphragmatic hernia in Denys-Drash syndrome Am J Med Genet 1995 57 97 101 10.1002/ajmg.1320570120 7645607
58 Cho HY Lee BS Kang CH et al Hydrothorax in a patient with Denys-Drash syndrome associated with a diaphragmatic defect Pediatr Nephrol 2006 21 1909 12 10.1007/s00467-006-0273-5 16932893
59 Antonius T van Bon B Eggink A et al Denys–Drash syndrome and congenital diaphragmatic hernia: another case with the 1097G > A(Arg366His) mutation Am J Med Genet Pt A 2008 146A 496 9 10.1002/ajmg.a.32168
60 Denamur E Bocquet N Baudouin V et al WT1 splice-site mutations are rarely associated with primary steroid-resistant focal and segmental glomerulosclerosis Kidney Int 2000 57 1868 72 10.1046/j.1523-1755.2000.00036.x 10792605
61 Slavotinek AM Single gene disorders associated with congenital diaphragmatic hernia Am J Med Genet C Semin Med Genet 2007 145C 172 83 10.1002/ajmg.c.30125 17436300
62 Veiga-Fernández A Joigneau Prieto L Álvarez T et al Perinatal diagnosis and management of early-onset Marfan syndrome: case report and systematic review J Matern Fetal Neonatal Med 2020 33 2493 504 10.1080/14767058.2018.1552935 30652519
63 Qi H Yu L Zhou X et al De novo variants in congenital diaphragmatic hernia identify MYRF as a new syndrome and reveal genetic overlaps with other developmental disorders PLoS Genet 2018 14 e1007822 10.1371/journal.pgen.1007822 30532227
64 Russell MK Longoni M Wells J et al Congenital diaphragmatic hernia candidate genes derived from embryonic transcriptomes Proc Natl Acad Sci U S A 2012 109 2978 83 10.1073/pnas.1121621109 22315423
65 Zaidi S Choi M Wakimoto H et al De novo mutations in histone-modifying genes in congenital heart disease Nat New Biol 2013 498 220 3 10.1038/nature12141
66 Rossetti LZ Glinton K Yuan B et al Review of the phenotypic spectrum associated with haploinsufficiency of MYRF Am J Med Genet A 2019 179 1376 82 10.1002/ajmg.a.61182 31069960
67 Gupta VS Khan AM Ebanks AH et al Cornelia de Lange syndrome and congenital diaphragmatic hernia J Pediatr Surg 2021 56 697 9 10.1016/j.jpedsurg.2020.06.003 32762940
68 Chong K Saleh M Injeyan M et al Nonisolated diaphragmatic hernia in Simpson-Golabi-Behmel syndrome Prenat Diagn 2018 38 117 22 10.1002/pd.5198 29240237
69 Twigg SRF Kan R Babbs C et al Mutations of ephrin-B1 (EFNB1), a marker of tissue boundary formation, cause craniofrontonasal syndrome Proc Natl Acad Sci U S A 2004 101 8652 7 10.1073/pnas.0402819101 15166289
70 Vasudevan PC Twigg SRF Mulliken JB et al Expanding the phenotype of craniofrontonasal syndrome: two unrelated boys with EFNB1 mutations and congenital diaphragmatic hernia Eur J Hum Genet 2006 14 884 7 10.1038/sj.ejhg.5201633 16639408
71 Acosta-Fernández E Zenteno JC Chacón-Camacho OF et al Extracranial midline defects in a patient with craniofrontonasal syndrome with a novel EFNB1 mutation Am J Med Genet A 2020 182 1223 9 10.1002/ajmg.a.61506 32022998
72 Salzano E Raible SE Kaur M et al Prenatal profile of Pallister-Killian syndrome: retrospective analysis of 114 pregnancies, literature review and approach to prenatal diagnosis Am J Med Genet A 2018 176 2575 86 10.1002/ajmg.a.40499 30289601
73 Longoni M Lage K Russell MK et al Congenital diaphragmatic hernia interval on chromosome 8p23.1 characterized by genetics and protein interaction networks Am J Med Genet A 2012 158A 3148 58 10.1002/ajmg.a.35665 23165946
74 Cannata G Caporilli C Grassi F et al Management of Congenital Diaphragmatic Hernia (CDH): Role of Molecular Genetics Int J Mol Sci 2021 22 6353 10.3390/ijms22126353 34198563
75 Zani A Chung WK Deprest J et al Congenital diaphragmatic hernia Nat Rev Dis Primers 2022 8 37 10.1038/s41572-022-00362-w 35650272
76 Molkentin JD The zinc finger-containing transcription factors GATA-4, -5, and -6. Ubiquitously expressed regulators of tissue-specific gene expression J Biol Chem 2000 275 38949 52 10.1074/jbc.R000029200 11042222
77 Kammoun M Souche E Brady P et al Genetic profile of isolated congenital diaphragmatic hernia revealed by targeted next-generation sequencing Prenat Diagn 2018 38 654 63 10.1002/pd.5327 29966037
78 Škorić-Milosavljević D Tjong FVY Barc J et al GATA6 mutations: characterization of two novel patients and a comprehensive overview of the GATA6 genotypic and phenotypic spectrum Am J Med Genet A 2019 179 1836 45 10.1002/ajmg.a.61294 31301121
79 Takahashi T Friedmacher F Zimmer J et al Gata-6 expression is decreased in diaphragmatic and pulmonary mesenchyme of fetal rats with nitrofen-induced congenital diaphragmatic hernia Pediatr Surg Int 2018 34 315 21 10.1007/s00383-017-4219-8 29196881
80 Keijzer R Tuyl M van Meijers C et al The transcription factor GATA6 is essential for branching morphogenesis and epithelial cell differentiation during fetal pulmonary development Dev (Rome) 2001 128 503 11 10.1242/dev.128.4.503
81 Zhang Y Goss AM Cohen ED et al A Gata6-Wnt pathway required for epithelial stem cell development and airway regeneration Nat Genet 2008 40 862 70 10.1038/ng.157 18536717
82 Ackerman KG Herron BJ Vargas SO et al Fog2 is required for normal diaphragm and lung development in mice and humans PLoS Genet 2005 1 58 65 e10 10.1371/journal.pgen.0010010 16103912
83 Longoni M Russell MK High FA et al Prevalence and penetrance of ZFPM2 mutations and deletions causing congenital diaphragmatic hernia Clin Genet 2015 87 362 7 10.1111/cge.12395 24702427
84 Klaassens M van Dooren M Eussen HJ et al Congenital diaphragmatic hernia and chromosome 15q26: determination of a candidate region by use of fluorescent in situ hybridization and array-based comparative genomic hybridization Am J Hum Genet 2005 76 877 82 10.1086/429842 15750894
85 Qiao L Xu L Yu L et al Rare and de novo variants in 827 congenital diaphragmatic hernia probands implicate LONP1 as candidate risk gene Am J Hum Genet 2021 108 1964 80 10.1016/j.ajhg.2021.08.011 34547244
86 Schulz F Jenetzky E Zwink N et al Parental risk factors for congenital diaphragmatic hernia - a large German case-control study BMC Pediatr 2021 21 278 10.1186/s12887-021-02748-3 34126946
87 Yang W Shaw GM Carmichael SL et al Nutrient intakes in women and congenital diaphragmatic hernia in their offspring Birth Defects Res 2008 82 131 8 10.1002/bdra.20436
88 Beurskens LWJE Schrijver LH Tibboel D et al Dietary vitamin A intake below the recommended daily intake during pregnancy and the risk of congenital diaphragmatic hernia in the offspring Birth Defects Res 2013 97 60 6 10.1002/bdra.23093
89 Michikawa T Yamazaki S Sekiyama M et al Maternal dietary intake of vitamin A during pregnancy was inversely associated with congenital diaphragmatic hernia: the Japan Environment and Children’s Study Br J Nutr 2019 122 1295 302 10.1017/S0007114519002204 31474242
90 Molotkov A Duester G Retinol/ethanol drug interaction during acute alcohol intoxication in mice involves inhibition of retinol metabolism to retinoic acid by alcohol dehydrogenase J Biol Chem 2002 277 22553 7 10.1074/jbc.M201603200 11960985
91 Yilmaz G Isik Agras P Hizli S et al The effect of passive smoking and breast feeding on serum antioxidant vitamin (A, C, E) levels in infants Acta Paediatr 2009 98 531 6 10.1111/j.1651-2227.2008.01084.x 19006535
92 Carmichael SL Ma C Witte JS et al Congenital diaphragmatic hernia and maternal dietary nutrient pathways and diet quality Birth Defects Res 2020 112 1475 83 10.1002/bdr2.1770 32744808
93 Rivas JFG Clugston RD The etiology of congenital diaphragmatic hernia: the retinoid hypothesis 20 years later Pediatr Res 2024 95 912 21 10.1038/s41390-023-02905-7 37990078
94 Greer JJ Babiuk RP Thebaud B Etiology of congenital diaphragmatic hernia: the retinoid hypothesis Pediatr Res 2003 53 726 30 10.1203/01.PDR.0000062660.12769.E6 12621107
95 Gilbert RM Gleghorn JP Connecting clinical, environmental, and genetic factors point to an essential role for vitamin A signaling in the pathogenesis of congenital diaphragmatic hernia Am J Physiol Lung Cell Mol Physiol 2023 324 L456 67 10.1152/ajplung.00349.2022 36749917
96 Rocke AW Clarke TG Dalmer TRA et al Low maternal vitamin A intake increases the incidence of teratogen induced congenital diaphragmatic hernia in mice Pediatr Res 2022 91 83 91 10.1038/s41390-021-01409-6 33654278
97 Mey J Babiuk RP Clugston R et al Retinal dehydrogenase-2 is inhibited by compounds that induce congenital diaphragmatic hernias in rodents Am J Pathol 2003 162 673 9 10.1016/S0002-9440(10)63861-8 12547725
98 Beecroft SJ Ayala M McGillivray G et al Biallelic hypomorphic variants in ALDH1A2 cause a novel lethal human multiple congenital anomaly syndrome encompassing diaphragmatic, pulmonary, and cardiovascular defects Hum Mutat 2021 42 506 19 10.1002/humu.24179 33565183
99 Song M Yuan X Racioppi C et al GATA4/5/6 family transcription factors are conserved determinants of cardiac versus pharyngeal mesoderm fate Sci Adv 2022 8 eabg0834 10.1126/sciadv.abg0834 35275720
100 Goumy C Gouas L Marceau G et al Retinoid Pathway and Congenital Diaphragmatic Hernia: Hypothesis from the Analysis of Chromosomal Abnormalities Fetal Diagn Ther 2010 28 129 39 10.1159/000313331 20501978
101 Guadix JA Ruiz-Villalba A Lettice L et al Wt1 controls retinoic acid signalling in embryonic epicardium through transcriptional activation of Raldh2 Development (Rome) 2011 138 1093 7 10.1242/dev.044594
102 Carmona R Cañete A Cano E et al Conditional deletion of WT1 in the septum transversum mesenchyme causes congenital diaphragmatic hernia in mice Elife 2016 5 e16009 10.7554/eLife.16009 27642710
103 Jonk LJ de Jonge ME Pals CE et al Cloning and expression during development of three murine members of the COUP family of nuclear orphan receptors Mech Dev 1994 47 81 97 10.1016/0925-4773(94)90098-1 7947324
104 Lu JR McKinsey TA Xu H et al FOG-2, a heart- and brain-enriched cofactor for GATA transcription factors Mol Cell Biol 1999 19 4495 502 10.1128/MCB.19.6.4495 10330188
105 Doi T Sugimoto K Puri P Prenatal retinoic acid up-regulates pulmonary gene expression of COUP-TFII, FOG2, and GATA4 in pulmonary hypoplasia J Pediatr Surg 2009 44 1933 7 10.1016/j.jpedsurg.2009.04.027 19853750
106 Clabby ML Robison TA Quigley HF et al Retinoid X receptor alpha represses GATA-4-mediated transcription via a retinoid-dependent interaction with the cardiac-enriched repressor FOG-2 J Biol Chem 2003 278 5760 7 10.1074/jbc.M208173200 12480945
